Phenotypic Effect of α-Globin Gene Numbers on Indian Sickle β-Thalassemia Patients

Journal of Clinical Laboratory Analysis

Volumn 28, Issue 2, 2014, Pages 110-113

  Pandey, Sanjay Kumar ^a   Pandey, Sweta ^a   Ranjan, Ravi ^a   Shah, Vineet ^a   Mishra, Rahasya Mani ^b   Sharma, Monica ^a   Saxena, Renu ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b A P S UNIVERSITY   (India)

Author keywords

ARMS PCR; Gap PCR; SCD; Sickle thalassemia; thalassemia

Indexed keywords

HEMOGLOBIN;

ALPHA GLOBIN GENE; ARTICLE; CHILD; CLINICAL FEATURE; FEMALE; GENE DELETION; GENE NUMBER; GENOTYPE; GLOBIN GENE; HEMATOLOGICAL PARAMETERS; HEMATOLOGY ANALYZER; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MUTATIONAL ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; SICKLE CELL BETA THALASSEMIA;

ARMS-PCR; GAP-PCR; SCD; SICKLE Β-THALASSEMIA; Α-THALASSEMIA;

ALPHA-GLOBINS; ANEMIA, SICKLE CELL; BETA-THALASSEMIA; CHILD; FEMALE; GENE DOSAGE; HUMANS; INDIA; MALE; PHENOTYPE;

EID: 84896137985     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21652     Document Type: Article

References (43)

1. Serjeant GR. The clinical features of sickle cell disease. In: Bearn AG, Black DAK, Hiatt HH, editors. Clinical Studies, Vol. 4. Amsterdam: North-Holland Publishing Company; 1974. p. 59.
2. Weatherall DJ, Clegg JB, Blankson J, McNeil JR. A new sickling disorder resulting from interaction of the genes of hemoglobin S and alpha-thalassaemia. Br J Hematol 1969;17:517-526.
3. Afonja OA. Osteoblastic activity in sickle cell disease. Clin Chem Newsletter 1982;3:161-163.
4. Mohanty D, Mukherjee MB. Sickle cell disease in India. Curr Opin Hematol 2002;9:117-122.
5. Mohanty D, Colah R, Gorakshakar A. Jai Vigyan S and T mission project on Community control of thalassemia syndromes-Awareness, screening, genetic counseling and prevention-A national multicentric task force study of ICMR. New Delhi. 2008.
6. Serjeant GR. Sickle cell- β thalassemia. In: Serjeant GR, editor. Sickle Cell Disease, Third edition. Oxford: Oxford University Press; 2001.
7. Weatherall DJ, Clegg JB. The Thalassemia Syndromes. Oxford: Blackwell Scientific Publications; 1981.
8. Wainscoat JS, Kanavakis E, Wood WG, et al. Thalassemia intermedia in Cyprus. The interaction of alpha and beta thalassemia. Br J Haematol 1983;53:411-416.
9. Galanello R, Dessi E, Melis MA, et al., Molecular analysis of β0-thalassemia intermedia in Sardinia. Blood 1989;74:823-827.
10. Kanavakis E, Metaxotou-Mavromati A, Kattamis C, Wainscoat JS, Wood WG. The triplicated alpha gene locus and β-thalassemia. Br J Haematol 1983;54:201-207.
11. Kulozik AE, Thein SL, Wainscoat JS, et al., Thalassemia intermedia: Interaction of the triple alpha-globin gene arrangement and heterozygous ß-halassemia. Br J Haematol 1987;66:109-112.
12. Traeger-Synodinos J, Kanavakis E, Vrettou C, et al. The triplicated α-globin gene locus in ß-thalassemia heterozygotes: Clinical, haematological, biosynthetic and molecular studies. Br J Haematol 1996;95:467-471.
13. Thein SL, Al-Hakim I, Hoffbrand AV. Thalassemia intermedia: A new molecular basis. Br J Haematol 1984;56:333-337.
14. 0-thalassemia and triplicated alpha globin loci in a Swiss-Spanish family. Klin Wochenschr 1991;69:710-714.
15. Sampietro M, Cazzola M, Cappelini MD, Fiorelli G. The triplicated alpha gene locus and heterozygous beta thalassemia: A case of thalassemia intermedia. Br J Haematol 1983;55:709-710.
16. Altay C, Basak AN. Molecular basis and prenatal diagnosis of hemoglobinopathies in Turkey. Int J Pediatr Hematol Oncol 1995;2:283-290.
17. Rund D, Oron-Karni V, Filon D, Goldfarb A, Rachmilewitz E, Oppenheim A. Genetic analysis of β thalassemia intermedia in Israel: Diversity of mechanisms and unpredictability of phenotype. Am J Hematol 1997;54:16-22.
18. Oron V, Filon D, Oppenheim A, Rund D. Severe thalassemia intermedia caused by interaction of homozygosity for alpha-globin gene triplication with heterozygosity for ß0-thalassemia. Br J Haematol 1994;86:377-379.
19. Chan V, Chan TK, Cheng MY, Kan YW, Todd D. Organization of the zeta-alpha genes in Chinese. Br J Haematol 1986;64:97-105.
20. Goossens M, Dozy AM, Embury SH, et al. Triplicated alpha-globin loci in humans. Proc Natl Acad Sci USA 1980;77:518-521.
21. Baysal E, Huisman THJ. Detection of common deletional alpha thalassemia-2 determinants by Gap-PCR. Am J Hematol. 1994;46:208-213.
22. Smetanina NS, Huisman TH. Detection of alpha-thalassemia-2. (-3.7 kb) and its corresponding triplication ααα (anti-3.7 kb) by PCR: An improved technical change. Am J Hematol. 1996;53(3):202-203.
23. Shaji RV, Eunice SE, Baidya S, Srivastava A, Chandy M. Determination of the breakpoint and molecular diagnosis of a common alpha thalassemia-1deletion in the Indian population. Br J Haematol 2003;123:942-947.
24. Chang JG, Lee LS, Lin CP, Chen PH, Chen CP. Rapid diagnosis of alpha thalassemia-1 of Southeast Asia type and hydrops fetalis by polymerase chain reaction. Blood 1991;78:853-854.
25. Varawalla NY, Old JM, Sarkar R, Venkatesan R, Weatherall DJ. The spectrum of beta thalassemia mutations on the Indian subcontinent: The basis for prenatal diagnosis. Br J Haematol 1991;78:242-247.
26. Silvestroni E, Bianco I. Microdrepanocito-anemia in un soggetto di razza Bianca. Boll A Acad Med Roma 1944;70:347-351.
27. Balagir RS. Aberrant hetrosis in hemoglobinopathies with special reference to beta thalassemia and structurally abnormal hemoglobins E and S in Orissa, India. J Clin Diagn Res 2007;1(3):122-130.
28. Weatherall DJ, Clegg JB. The Thalassemia Syndromes, Fourth edition. Oxford: Blackwell Scientific Publications; 2001.
29. Altay C, Oner C, Oner R, Gümrük F, Mergen H, Gürgey A. Effect of α-gene numbers on the expression of ß-thalassemia intermedia, ß-thalassemia and (δß)0-thalassemia traits. Hum Hered 1998;48:121-125.
30. Altay C, Gravely ME, Joseph BR, Williams DF. Alpha-thalassemia-2 and the variability of hematological values in children with sickle cell anemia. Pediatr Res 1981;15:1093-1096.
31. Thein SL. Genetic insights into the clinical diversity of beta thalassaemia. Br J Haematol 2004;124:264-274.
32. Weatherall DJ. Phenotype-genotype relationships in monogenic disease: Lessons from the thalassaemias. Nat Rev Genet 2001;2:245-255.
33. Quinn CT, Miller ST. Risk factors and prediction of outcomes in children and adolescents who have sickle cell anemia. Hematol Oncol Clin North Am 2004;18:1339-1354.
34. Steinberg MH, Rodgers GP. Pathophysiology of sickle cell disease: Role of cellular and genetic modifiers. Semin Hematol 2001;38:299-306.
35. Steinberg MH. Predicting clinical severity in sickle cell anaemia. Br J Haematol 2005;129:465-481.
36. Rund D, Fucharoen S. Genetic modifiers in hemoglobinopathies. Curr Mol Med 2008;8(7):600-608.
37. Fucharoen S, Winichagoon P. Clinical and hematologic aspects of hemoglobin E [beta]-thalassemia. Curr Opin Hemat 2000;7(2):106-112.
38. Nadkarni A, Ghosh K, Gorakshakar A, Colah R, Mohanty D. Variable clinical severity of Hb E beta-thalassemia among Indians. J Assoc Physicians India 1999;47(10):966-968.
39. Other Significant Heoglobinopathies. In: Bain BJ, editor. Hemoglobinopathy Diagnosis, First edition. London: Blackwell Science; 2001. p. 154-186.
40. Panigrahi I, Agarwal S, Gupta T, Singhal P, Pradhan M. Hemoglobin E-beta thalassemia: Factors affecting phenotype. Indian Pediatr 2005;42(4):357-362.
41. Pandey S, Pandey SW, Sharma M, Mishra RM, Saxena R. Genotypic influence of α-deletions on the phenotype of Indian sickle cell anemia patients. Korean J Hematol 2011;46:192-195.
42. Yuan J, Bunyaratvej A, Fucharoen S, Fung C, Shinar E, Schrier SL. The instability of the membrane skeleton in thalassemic red blood cells. Blood 1995;86:3945-3950.
43. Schrier SL. Pathophysiology of Alpha Thalassemia. Waltham, MA: UpToDate, Inc; 2012.